Abstract | BACKGROUND: AIM: METHODS: We searched in three electronic databases from inception to December 2020 for randomized controlled trials (RCTs). Outcomes were mortality, intensive care unit (ICU) admission, hospital stay, and Systemic Inflammatory Response Syndrome (SIRS) at 24, 48, and 72 h. The risk of bias was assessed using the Risk of Bias 2.0 tool. All meta-analyses were performed using a random-effects model. RESULTS: Four RCTs comprising 248 patients were included. The mean age ranged from 42.3 to 63.8 years and 49% of patients were men. Patients treated with LR had similar risk of mortality (risk ratio [RR], 0.53; 95% confidence interval [CI], 0.09-3.00) and SIRS at 24 h (RR, 0.69; 95% CI, 0.32-1.51), 48 h (RR, 0.80; 95% CI, 0.46-1.41), and 72 h (RR, 0.68; 95% CI, 0.37-1.25) compared to NS. LR had significantly lower hospital stay (mean difference, - 1.10; 95% CI, - 1.92 to - 0.28) and lower risk of ICU admission (RR, 0.42; 95% CI, 0.20-0.89) compared to NS. The risk of bias was low in nearly all RCTs. CONCLUSION: No differences were found in the mortality and SIRS at 24, 48, and 72 h in patients treated with LR and NS. In contrast, patients who received LR had a lower risk of ICU admission and lower hospital stay than NS.
|
Authors | Edson Guzmán-Calderón, Carlos Diaz-Arocutipa, Eduardo Monge |
Journal | Digestive diseases and sciences
(Dig Dis Sci)
Vol. 67
Issue 8
Pg. 4131-4139
(08 2022)
ISSN: 1573-2568 [Electronic] United States |
PMID | 34635979
(Publication Type: Journal Article, Meta-Analysis, Systematic Review)
|
Copyright | © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
Chemical References |
- Lactates
- Ringer's Lactate
- Saline Solution
|
Topics |
- Adult
- Female
- Humans
- Lactates
- Male
- Middle Aged
- Pancreatitis
(therapy)
- Randomized Controlled Trials as Topic
- Ringer's Lactate
- Saline Solution
(therapeutic use)
- Systemic Inflammatory Response Syndrome
(therapy)
|